Cargando…

G-protein-signaling modulator 2 expression and role in a CD133(+) pancreatic cancer stem cell subset

BACKGROUND: To investigate the expression and role of G-protein-signaling modulator 2 (GPSM2) in a CD133(+) pancreatic stem cell subset. MATERIALS AND METHODS: Pancreatic cancer stem cells (PCSCs) from the cell line PANC-1 were sorted into CD133(+) and CD133(−) subsets by flow cytometry. The tumorig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dang, Sheng-Chun, Qian, Xiao-Bao, Jin, Wei, Cui, Lei, Chen, Ji-Xiang, Gu, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352860/ https://www.ncbi.nlm.nih.gov/pubmed/30774366 http://dx.doi.org/10.2147/OTT.S187670

Ejemplares similares

Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells
por: Xue, Zhan-Xiong, et al.
Publicado: (2014)

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
por: Rountree, C. Bart, et al.
Publicado: (2011)

Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
por: Immervoll, Heike, et al.
Publicado: (2008)

The CD133(+) Stem/Progenitor-Like Cell Subset Is Increased in Human Milk and Peripheral Blood of HIV-Positive Women
por: Valverde-Villegas, Jacqueline María, et al.
Publicado: (2020)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis
por: Durko, L., et al.
Publicado: (2017)

CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells
por: Maeda, Koki, et al.
Publicado: (2016)

Corrigendum to “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis”
por: Durko, L., et al.
Publicado: (2017)

CD133: a stem cell biomarker and beyond
por: Li, Zhong
Publicado: (2013)

Prostate Cancer Stem Cells: The Role of CD133
por: Yang, Jianhui, et al.
Publicado: (2022)

CD133, Stem Cells, and Cancer Stem Cells: Myth or Reality?
por: Yu, Xiazhen, et al.
Publicado: (2011)

Minnelide effectively eliminates CD133(+) side population in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015)

The effect and molecular mechanism of hypoxia on proliferation and apoptosis of CD133(+) renal stem cells
por: Liu, Hong, et al.
Publicado: (2021)

The Potential Role of CD44 and CD133 in Colorectal Stem Cell Cancer
por: Abdou Hassan, Wael, et al.
Publicado: (2022)

Significance of CD133 as a cancer stem cell markers focusing on the tumorigenicity of pancreatic cancer cell lines
por: Lee, Hyun Joo, et al.
Publicado: (2011)

Tumour stem cell markers CD133 and CD44 are useful prognostic factors after surgical resection of pancreatic neuroendocrine tumours
por: Sun, Zhonghai, et al.
Publicado: (2020)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma
por: ZHOU, FEI, et al.
Publicado: (2014)

Production of interleukin-4 in CD133(+) cervical cancer stem cells promotes resistance to apoptosis and initiates tumor growth
por: LIU, CHUN-TAO, et al.
Publicado: (2016)

Production of interleukin-4 in CD133+ cervical cancer stem cells promotes resistance to apoptosis and initiates tumor growth
por: Liu, Chun-Tao, et al.
Publicado: (2016)

Cancer stem cells CD133 and CD24 in colorectal cancers in Northern Iran
por: Nosrati, Anahita, et al.
Publicado: (2016)

Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma
por: Nosrati, Anahita, et al.
Publicado: (2014)

Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer
por: WANG, CHUNXIA, et al.
Publicado: (2012)

Clonal dominance of CD133(+) subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma
por: SHARMA, BHUVNESH K., et al.
Publicado: (2012)

CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells
por: Barrantes-Freer, Alonso, et al.
Publicado: (2015)

Suitability of CD133 as a Marker for Cancer Stem Cells in Melanoma
por: Korn, Philippe, et al.
Publicado: (2021)

Immunohistochemical Expression of the Stem Cell Marker CD133 in Colorectal Carcinoma
por: Suman, Sweta, et al.
Publicado: (2023)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

Label-free quantitative proteomics of CD133-positive liver cancer stem cells
por: Tsai, Sheng-Ta, et al.
Publicado: (2012)

Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133(+) pancreatic cancer stem-like cells
por: Zhu, Haitao, et al.
Publicado: (2013)

G Protein-Coupled Receptor 87 (GPR87) Promotes the Growth and Metastasis of CD133(+) Cancer Stem-Like Cells in Hepatocellular Carcinoma
por: Yan, Mingxia, et al.
Publicado: (2013)

Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133(+) osteosarcoma cancer stem cells
por: Ni, Miaozhong, et al.
Publicado: (2015)

CD133-Targeted Hybrid Nanovesicles for Fluorescent/Ultrasonic Imaging-Guided HIFU Pancreatic Cancer Therapy
por: Wang, Rui, et al.
Publicado: (2023)

A Novel Function for KLF4 in Modulating the De-Differentiation of EpCAM(−)/CD133(−) nonStem Cells into EpCAM(+)/CD133(+) Liver Cancer Stem Cells in HCC Cell Line HuH7
por: Firtina Karagonlar, Zeynep, et al.
Publicado: (2020)

Low Concentrations of Metformin Selectively Inhibit CD133(+) Cell Proliferation in Pancreatic Cancer and Have Anticancer Action
por: Gou, Shanmiao, et al.
Publicado: (2013)

CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure
por: Tsunekuni, Kenta, et al.
Publicado: (2019)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Isolation of Swine Bone Marrow Lin-/CD45-/CD133 + Cells and Cardio-protective Effects of its Exosomes
por: Li, Hongxiao, et al.
Publicado: (2022)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_0h541q37k9an2d07qv9o9m745h